Save your place

Sign in to WhoBought

Please try again later.

Joel Greenblatt's Doximity, Inc. (DOCS) position

Yes: as of Q1 2026, Joel Greenblatt holds 1.3M shares of DOCS worth $30M (0.1% of the disclosed portfolio). Last quarter the position was increased by 261.7%. First disclosed Q3 2021.
View full portfolio →
Current value
$30M
Shares held
1.3M
% of portfolio
0.1%
Est. average buy price (i)
$39.91
est. since Q1 2025
Quarter-end price
$23.30

Estimated trade prices

Average price in quarters with purchases
$38.61
Average prices in quarters with sales
  • Q4 2023: $23.62 (8K shares sold)
  • Q1 2022: $50.33 (2K shares sold)

DOCS price vs Greenblatt's position

Dates
$10$50$100$15020222023202420252026New position of 7K shares · Q3 2021. Average closing price $73.14 · Price range $46.82–$102.027KsharespurchasedAdded 7K shares (96.9%) · Q4 2021. Average closing price $65.10 · Price range $48.39–$86.157KsharespurchasedSold 2K shares (12.7%) · Q1 2022. Average closing price $50.33 · Price range $40.56–$61.782KsharessoldNew position of 17K shares · Q3 2023. Average closing price $27.29 · Price range $19.86–$35.8317KsharespurchasedSold 8K shares (49.3%) · Q4 2023. Average closing price $23.62 · Price range $20.33–$28.428KsharessoldAdded 563 shares (6.5%) · Q1 2024. Average closing price $28.51 · Price range $26.91–$31.56563sharespurchasedAdded 32K shares (351.0%) · Q2 2024. Average closing price $26.38 · Price range $22.99–$29.8732KsharespurchasedAdded 39K shares (63.7%) · Q2 2025. Average closing price $55.79 · Price range $50.71–$61.3439KsharespurchasedAdded 220K shares (217.3%) · Q3 2025. Average closing price $65.20 · Price range $57.33–$75.12220KsharespurchasedAdded 40K shares (12.5%) · Q4 2025. Average closing price $56.14 · Price range $43.49–$73.5340KsharespurchasedAdded 944K shares (261.7%) · Q1 2026. Average closing price $31.16 · Price range $23.30–$46.49944Ksharespurchased
Average closing price · filing quarter
$31.16
Price range · filing quarter
$23.30 – $46.49

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +944K +$29M +261.7% 1.3M May 15, 2026
Q4 2025 Added +40K +$2.3M +12.5% 361K Feb 17, 2026
Q3 2025 Added +220K +$14M +217.3% 321K Nov 14, 2025
Q2 2025 Added +39K +$2.2M +63.7% 101K Aug 14, 2025
Q1 2025 First covered 62K May 15, 2025
Q4 2024 First covered 48K Feb 14, 2025
Q3 2024 First covered 54K Nov 14, 2024
Q2 2024 Added +32K +$856K +351.0% 42K Aug 14, 2024
Q1 2024 Added +563 +$16K +6.5% 9K May 15, 2024
Q4 2023 Reduced −8K −$200K −49.3% 9K Feb 14, 2024
Q3 2023 New +17K +$468K 17K Nov 14, 2023
Q1 2022 Reduced −2K −$85K −12.7% 12K May 16, 2022
Q4 2021 Added +7K +$426K +96.9% 13K Feb 14, 2022
Q3 2021 New +7K +$494K 7K Nov 15, 2021
Data through Q1 2026 · filed May 15, 2026
14 grouped rows from 14 quarters

More Greenblatt positions

Common questions

Does Joel Greenblatt own DOCS?

Yes. As of Q1 2026, Joel Greenblatt disclosed 1.3M shares of DOCS, worth $30M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Joel Greenblatt buy DOCS?

Joel Greenblatt first disclosed a DOCS position in Q3 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Joel Greenblatt sell DOCS?

The quarter-by-quarter table above shows each sale and reduction Joel Greenblatt disclosed in DOCS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of DOCS does Joel Greenblatt own?

Joel Greenblatt disclosed 1.3M shares of DOCS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Joel Greenblatt pay for DOCS?

Joel Greenblatt began building the DOCS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.